Samsung Celecoxib Capsule 200 mg

Adult dose

The minimum recommended dose of this medicine should be adjusted for each patient. It may be administered without regard to meals. ○ Adults 1. Osteoarthritis (degenerative arthritis) Take celecoxib 200 mg once daily, or 100 mg per dose twice daily. 2. Rheumatoid arthritis Take celecoxib 100 mg or 200 mg per dose twice daily. 3. Ankylosing spondylitis (AS) Administer celecoxib 200 mg once daily, or 100 mg per dose twice daily. If no effect is observed after 6 weeks, the dose may be increased to 400 mg daily. If no effect is observed after 6 weeks of treatment at 400 mg daily, consider another treatment. 4. Acute pain and primary dysmenorrhea The recommended initial dose is celecoxib 400 mg, with an additional 200 mg on the first day of treatment if needed. From the second day of treatment, the recommended dose, if needed, is 200 mg per dose twice daily. ○ Patients with hepatic impairment For patients with moderate hepatic impairment (Child-Pugh Class II), the dose should be reduced to approximately 50% of the recommended daily dose.

This drug may cause gastrointestinal bleeding in individuals who regularly consume more than three alcoholic beverages per day, therefore, it is essential to consult a doctor or pharmacist. This drug may increase the risk of cardiovascular thrombosis, myocardial infarction, and stroke, so patients with a history of cardiovascular disease or risk factors should be particularly cautious. This medication may cause serious gastrointestinal adverse reactions such as gastrointestinal perforation, ulcers, and bleeding, and therefore should be used with caution in elderly patients or those with a history of gastrointestinal diseases. This drug should not be administered to individuals with specific allergic histories, severe liver or kidney impairment, active gastric ulcers, heart failure, or women who are pregnant. Patients with reduced liver or kidney functions, asthma, hypertension, or heart failure should use this drug with caution, and regular tests may be required during treatment. Side effects such as dyspepsia, diarrhea, dizziness, headaches, hypertension, and edema may occur, so any unusual symptoms should be immediately reported to healthcare professionals. Since this drug is metabolized in the liver, there may be interactions with other medications; patients taking other medications should inform their doctor or pharmacist. Women who are pregnant, may become pregnant, or are breastfeeding should not take this drug, and women planning to become pregnant should consult before taking it. When administered to the elderly, careful monitoring of kidney and heart function is advisable, and the lowest effective dose for the shortest duration should be considered. Prolonged use of this drug may require regular blood tests and liver and kidney function tests, and any abnormal signs should result in immediate discontinuation of the drug. In case of overdose, symptoms such as nausea, vomiting, lethargy, and gastrointestinal bleeding may arise, and appropriate medical treatment should be sought immediately. This drug should be kept out of reach of children, and transferring it to other containers may compromise its quality, so caution is advised.

Gastrointestinal bleeding, cardiovascular thromboembolic reactions, myocardial infarction, stroke, perforation of the upper and lower gastrointestinal tract, ulcer, bleeding, bronchitis, sinusitis, upper respiratory tract infection, urinary tract infection, pharyngitis, rhinitis, anemia, thrombocytopenia, hypersensitivity, insomnia, anxiety, confusion, dizziness, muscle hypertonicity, drowsiness, blurred vision, tinnitus, palpitations, congestive heart failure, arrhythmia, tachycardia, hypertension, flushing, cough, vomiting, abdominal pain, diarrhea, dyspepsia, bloating, gastric ulcer, dental disease, duodenal ulcer, esophageal ulcer, intestinal perforation, pancreatitis, elevated liver enzymes, itching, rash, urticaria, petechiae, angioedema, alopecia, vesicular dermatitis, peripheral edema, facial edema, influenza-like illness, injuries, taste disturbance, albuminuria, cystitis, hematuria, dysuria, polyuria, nephrolithiasis, urinary incontinence, urinary tract infection, visual haze, cataract, conjunctivitis, eye pain, glaucoma, ocular hemorrhage, retinal artery or vein obstruction, elevated serum creatinine, increased β2-microglobulin, increased NAG, positive urinary hematuria, positive urinary protein, renal dysfunction, acute renal failure, interstitial nephritis, elevated serum sodium, elevated serum potassium, increased BUN, increased CPK, diabetes mellitus, hypercholesterolemia, hyperglycemia, hypokalemia, hyperkalemia, increased NPN, elevated creatinine, increased alkaline phosphatase, weight gain, loss of appetite, increased LDH, hypoglycemia, hyponatremia, bursitis, arthralgia, arthrosis, skeletal abnormalities, myalgia, cervical tension syndrome, synovitis, tendinitis, myositis, leg cramps, fractures, tendon rupture, pain in the waist, muscle rigidity, decreased hematocrit, increased hemoglobin, petechiae, nosebleeds, thrombocytopathy, anemia, thrombocytopenia, agranulocytosis, aplastic anemia, pancytopenia, leukopenia, granulomatous inflammation, contact dermatitis, injection site reactions, skin nodules, chest pain, headache, dizziness, constipation, thirst, ulcerative stomatitis, gastritis, allergies, low back pain, hyperlipidemia, hearing loss, anaphylaxis, hallucinations, cerebral hemorrhage, aseptic meningitis, loss of taste, loss of smell, vasculitis, pulmonary embolism, interstitial pneumonia, hepatitis, liver failure, fulminant hepatitis, liver necrosis, cholestasis, cholestatic hepatitis, jaundice, photosensitivity reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, exfoliative dermatitis, acute renal failure, hyponatremia, tubulointerstitial nephritis, nephrotic syndrome, microangiopathic glomerulonephritis, menstrual disorders, female infertility

This drug should be stored in a tightly closed container to prevent the ingress of air or moisture. It is recommended to maintain a storage temperature between 15 to 30 degrees Celsius (room temperature).

Appearance

A white capsule filled with white to pale yellow powder, with a yellow band on both ends.

Package unit

30 capsules/bottle, 100 capsules/bottle